XEOMIN 100 unit
100 unit Botulinum toxin
Description
Xeomin (incobotulinumtoxinA, Merz) is a highly purified botulinum toxin type A product from which accessory complexing proteins have been removed, leaving only the active 150 kDa neurotoxin molecule. This protein-free formulation may reduce the risk of antibody formation with repeat treatments. Supplied as 100-unit lyophilised vials, it is FDA-approved and CE-marked for glabellar line correction (20 U standard dose) and upper-limb spasticity; aesthetic applications extend to crow's feet, forehead lines, and brow lifting.
Indication
Intended for professional aesthetic use within qualified clinical settings, administered by trained practitioners following manufacturer guidance.
Packaging
Supplied as a 100 unit vial of botulinum toxin type A in lyophilized form.
Protocol
Reconstitute the 100-unit vial with 2.5 mL of preservative-free 0.9% NaCl to yield 4 U/0.1 mL. For glabellar lines: inject 4 U per site (0.1 mL) into 5 sites — 2 in each corrugator muscle, 1 in procerus — using a 30–33G × 13 mm needle intramuscularly. Typical aesthetic full-face session uses 40–100 U. Onset within 3–7 days; duration up to 3–4 months. Refrigerate unused vials; use reconstituted product within 24 hours.
Related Products
#410
RESTYLANE VOLYME
1 mL x 1 Syr, HA 20 mg/mL, Lidocaine 0.3%
#412
RESTYLANE LYFT
1 mL x 1 Syr, HA 20 mg/mL, Lidocaine 0.3%
#409
RESTYLANE DEFYNE
1 mL x 1 Syr, HA 20 mg/mL, Lidocaine 0.3%
#411
RESTYLANE KYSSE
1 mL x 1 Syr, HA 20 mg/mL, Lidocaine 0.3%